Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2290-2299

  Inoue, Keiji ^a   Slaton, Joel W ^a   Kim, Sun Jin ^a   Perrotte, Paul ^a   Eve, Beryl Y ^a   Bar Eli, Menashe ^a   Radinsky, Robert ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CARCINOGENICITY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; COLLAGEN; COLLAGENASES; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; LAMININ; LYMPHATIC METASTASIS; LYMPHOKINES; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, ANTISENSE; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034655203     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer Statistics. CA Cancer J. Clin., 49: 8-31, 1999.
2. Skinner, D. G., and Lieskovksy, G. Management of invasive and high grade bladder cancer. In: D. Skinner and G. Lieskovsky (eds.). Genitourinary Cancer, pp. 295-312. Philadelphia: W. B. Saunders, 1988.
3. Caldwell, W. L. Carcinoma of the urinary bladder. J. Am. Med. Assoc., 16: 1643-1645, 1974.
4. Killion, J. J., and Fidler, I. J. The biology of tumor metastasis. Semin. Oncol., 16: 106-115, 1989.
5. Fidler, I. J., and Hart, R. I. Biological diversity in metastatic neoplasms: origins and implications. Science (Washington DC), 217: 998-1003, 1982.
6. Fidler, I. J., and Balch, C. M. The biology of cancer metastasis and implications for therapy. Curr. Probl. Surg., 24: 129-209, 1987.
7. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res., 50: 6130-6138, 1990.
8. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
9. Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes Memorial Award Lecture. Cancer Res., 46: 467-473, 1986.
10. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
11. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
12. Crew, J. P., O'Brien, T., Bradburn, M., Fuggle, S., Bicknell, R., Cranston, D., and Harris, A. L. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res., 51: 5281-5285, 1997.
13. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Different angiogenic pathways characterise superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
14. Allen, L. E., and Maher, P. A. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J. Cell. Physiol., 155: 368-375, 1993.
15. Nguyen, M., Watanabe, H., and Budson, A. E. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 85: 241-242, 1993.
16. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res., 57: 136-140, 1997.
17. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res., 56: 2515-2518, 1996.
18. Kubota, Y., Miura, T., Moriyama, M., Noguchi, S., Matsuzaki, J., Takebayashi, S., and Hosaka, M. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer. Clin. Cancer Res., 3: 973-976, 1997.
19. Tachibana, M., Miyakawa, A., Nakashima, J., Murai, M., Nakamura, K., Kubo, A., and Hata, J. I. Constitutive production of multiple cytokines and a human chorionic gonadotrophin β-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation. Br. J. Cancer, 76: 163-174, 1997.
20. Bochner, B. H., Cote, R. J., and Weidner, N. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst., 87: 1603-1612, 1995.
21. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., and Oppenheim, J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRN A by interleukin 1 and tumor necrosis factor. J Exp. Med., 167: 1883-1893, 1988.
22. Matsushima, K., Baldwin, E. T., and Mukaida, N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol., 51: 236-265, 1992.
23. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis [see comments]. Science (Washington DC), 258: 1798-1801, 1992.
24. Stricter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J., and Elner, S. G. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol., 141: 1279-1284, 1992.
25. Schadendorf, O., Moller, A., Algermissen, B., Worm, M., Sticherling, M., and Czarnetzki, B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 151: 2667-2675, 1993; erratum 153: 3360, 1994.
26. Schadendorf, O., Moller, A., Algermissen, B., Worm, M., Sticherling, M., and Czarnetzki, B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 151: 2667-2675, 1993; erratum 153: 3360, 1994.
27. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
28. Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., and Bar-Eli, M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol., 151: 1105-1113, 1997.
29. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., and Stricter, R. M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Investig., 97: 2792-2802, 1996.
30. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
31. Kitadai, Y., Haruma, K., Sumii, K., Yamamoto, S., Ue, T., Yokozaki, H., Yasui, W., Ohmoto, Y., Kajiyama, G., Fidler, I. J., and Tahara, E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol., 152: 93-100, 1998.
32. Yoneda, J., Kuniyasu, H., Crispens, M. A., Price, J. E., Bucana, C. D., and Fidler, I. J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst., 90: 447-454, 1998.
33. Dinney, C. P., Fishbeck, R., Singh, R. K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C. D., Fidler, I. J., and Killion, J. J. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 154: 1532-1538, 1995.
34. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsbrun, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1988.
35. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed dilferentially in normal tissues, macrophages, and tumors, Mol. Biol. Cell, 3: 211-220, 1992.
36. Fort, P., Marty, L., Piechaczyk, M., El Sabrouty, S., Dani, C., Jeanteur, P., and Blanchard, J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13: 1431-1442, 1985.
37. Feinherg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
38. Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., and Dinney, C. P. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin. Cancer Res., 5: 257-265, 1999.
39. Nakajima, M., Lotan, D., Baig, M. M., Carralero, R. M., Wood, W. R., Hendrix, M. J., and Lotan, R. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res., 49: 1698-1706, 1989.
40. Wei, Q., Guan, Y., Cheng, L., Radinsky, R., Bar-Eli, M., Tsan, R., Li, L., and Legerski, R. J. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction. Pathobiology, 65: 293-300, 1997.
41. Repesh, L. A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis. 9: 192-208, 1989.
42. Kitadai, Y., Bucana, C. D., Ellis, L. M., Anzai, H., Tahara, E., and Fidler, I. J. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am. J. Pathol., 147: 1238-1247, 1995.
43. Bucana, C. D., Radinsky, R., Dong, Z., Sanchez, R., Brigali, D. J., and Fidler, I. J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleolide probes for analysis of mdrl in mouse colon carcinoma cells. J. Histochem. Cytochem., 41: 499-506, 1993.
44. Radinsky, R., Bucana, C. D., Ellis, L. M., Sanchez, R., Cleary, K. R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res., 53: 937-943, 1993.
45. Reed, J. A., Manahan, L. J., Park, C. S., and Brigati, D. J. Complete one-hour immunocytochemistry based on capillary action. Biotechniques, 13: 434-443, 1992.
46. Vecchi, A., Garlanda, C., Lampugnani, M. G., Resnati, M., Matteucci, C., Stoppacciaro, A., Schnurch, H., Risau, W., Ruco, L., Mantovani, A., et al Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol., 63: 247-254, 1994.
47. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
48. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2: 1044-1051, 1982.
49. Hudson, J. M., Frade, R., and Bar, E. M. Wild-type p53 regulates its own transcription in a cell-type specific manner. DNA Cell Biol., 14: 759-766, 1945.
50. Moore, B. B., Arenberg, D. A., Stoy, K., Morgan, T., Addison, C. L., Morris, S. B., Glass, M., Wilke, C., Xue, Y. Y., Sitterding, S., Kunkel, S. L., Burdick, M. D., and Strieter, R. M. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol., 154: 1503-1512, 1999.
51. Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C., and Wood, W. I. Structure and functional expression of a human interleukin-8 receptor. Science (Washington DC), 253: 1278-1280, 1991.
52. Murphy, P. M., and Tiffany, H. L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science (Washington DC), 253: 1280-1283, 1991.
53. Singh, R., Reich, R., Radinsky, R., Berry, K., Dave, B., and Fidler, I. Expression of basic fibroblast growth factor is necessary but insufficient for production of metastasis. Int. J. Oncol., 10: 23-31, 1996.
54. Claffey, K. P. Brown, L. F., Tognazzi, K., Yeo, K. T., Manseau, E. J., and Dvorak, H. F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res., 56: 172-181, 1996.
55. McLeskey, S. W., Tobias, C. A., Vezza, P. R., Filie, A. C., Kern, F. G., and Hanfelt, J. Tumor growth of FGF or VEGF translected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor. Am. J. Pathol., 153: 1993-2006, 1998.
56. Kumar, R., Yoneda, J., Bucana, C. D., and Fidler, I. J. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int. J. Oncol., 12: 749-757, 1998.
57. Liotta, L. A., Thorgeirsson, U. P., and Garbisa, S. Role of collagenases in tumor cell invasion. Cancer Metastasis Rev., 1: 277-288, 1982.
58. Stetler-Stevenson, W. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9: 289-303, 1990.
59. Hamdy, F. C., Fadlon, E. J., Cottam, D., Lawry, J., Thurrell, W., Silcocks, P. B., Anderson, J. B., Williams, J. L., and Rees, R. C. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer, 69: 177-182, 1994.
60. Sehgal, G., Hua, J., Bernhard, E. J., Sehgal, I., Thompson, T. C., and Muschel, R. J. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma. Am. J. Pathol., 152: 591-596, 1998.
61. Festuccia, C., Dolo, V., Guerra, F., Violini, S., Muzi, P., Pavan, A., and Bologna, M. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin. Exp. Metastasis, 16: 513-528, 1998.
62. Stearns, M. E., and Stearns, M. Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a) expression in human prostate cancer. Oncol. Res., 8: 63-67, 1996.
63. Miyake, H., Hoshimura, K., Hara, I., Eto, H., Arakawa, S., and Kamidono, S. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J. Urol., 157: 2351-2355, 1997.